The global Cancer Biopsy market is poised for significant growth, as highlighted by recent market analysis. Valued at USD 26.24 billion in 2022, this dynamic market is expected to reach an impressive USD 61.06 billion by 2030, showcasing a robust Compound Annual Growth Rate (CAGR) of 11.13% over the forecast period from 2023 to 2030. Key Drivers of Growth: Increasing Cancer Incidence...